Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Submitted by
admin
on March 9, 2018 - 10:50am
Source:
Yahoo/Zacks.com
News Tags:
Pfizer
FDA
advisory panels
Xeljanz
ulcerative colitis
Headline:
Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Do Not Allow Advertisers to Use My Personal information
